相似文献
1
Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials.
Am J Public Health. 2002 Oct;92(10):1619-28. doi: 10.2105/ajph.92.10.1619.
2
A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B.
J Viral Hepat. 2000 May;7(3):225-9. doi: 10.1046/j.1365-2893.2000.00216.x.
3
[Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine].
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Dec;29(12):1243-7.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD000345. doi: 10.1002/14651858.CD000345.pub2.
6
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009004. doi: 10.1002/14651858.CD009004.pub2.
7
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
Cochrane Database Syst Rev. 2002(2):CD000345. doi: 10.1002/14651858.CD000345.
8
9
Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis.
J Viral Hepat. 2016 Mar;23(3):154-69. doi: 10.1111/jvh.12418. Epub 2015 May 13.
10
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
N Engl J Med. 2005 Jun 30;352(26):2682-95. doi: 10.1056/NEJMoa043470.
引用本文的文献
1
Metabolites from traditional Chinese botanical drugs with anti-hepatitis B virus activity - a review.
Front Pharmacol. 2024 Jul 12;15:1331967. doi: 10.3389/fphar.2024.1331967. eCollection 2024.
2
Recommendations and guidelines of integrative medicine for COVID-19 care: The APEC project outcome.
Integr Med Res. 2024 Mar;13(1):101022. doi: 10.1016/j.imr.2024.101022. Epub 2024 Feb 7.
3
/ Alleles Associate with Traditional Chinese Medicine Syndrome of Chronic Hepatitis B: A Potential Predictor of Progression.
Biomed Res Int. 2019 Nov 21;2019:8146937. doi: 10.1155/2019/8146937. eCollection 2019.
4
Preclinical Evaluation of and Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus.
Evid Based Complement Alternat Med. 2018 Jul 4;2018:1073509. doi: 10.1155/2018/1073509. eCollection 2018.
5
Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.
BMJ Open. 2017 Jan 25;7(1):e014571. doi: 10.1136/bmjopen-2016-014571.
6
Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
Molecules. 2016 Dec 27;22(1):14. doi: 10.3390/molecules22010014.
7
Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials.
Integr Cancer Ther. 2016 Sep;15(3):285-307. doi: 10.1177/1534735416638738. Epub 2016 May 4.
8
Hepatitis B screening among Chinese Americans: a structural equation modeling analysis.
BMC Infect Dis. 2015 Mar 8;15:120. doi: 10.1186/s12879-015-0854-7.
9
Extract from Phyllanthus urinaria L. inhibits hepatitis B virus replication and expression in hepatitis B virus transfection model in vitro.
Chin J Integr Med. 2015 Dec;21(12):938-43. doi: 10.1007/s11655-015-2076-7. Epub 2015 Apr 13.
10
Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):657-69. doi: 10.1007/s10096-012-1789-1. Epub 2012 Dec 18.
本文引用的文献
1
On estimating the relation between blood group and disease.
Ann Hum Genet. 1955 Jun;19(4):251-3. doi: 10.1111/j.1469-1809.1955.tb01348.x.
2
[A prospective study on histological and serological changes after interferon alpha-2b treatment in patients with chronic hepatitis B infection].
Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):145-7.
3
Prolonged interferon alpha treatment in children with chronic hepatitis B.
Ann Trop Paediatr. 2001 Mar;21(1):77-80. doi: 10.1080/02724930020028966.
4
Chinese medicinal herbs for chronic hepatitis B.
Cochrane Database Syst Rev. 2001;2000(1):CD001940. doi: 10.1002/14651858.CD001940.
5
Chronic hepatitis B virus infection in Asian countries.
J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x.
6
ABC of diseases of liver, pancreas, and biliary system: Chronic viral hepatitis.
BMJ. 2001 Jan 27;322(7280):219-21. doi: 10.1136/bmj.322.7280.219.
7
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.
Br J Surg. 2000 Nov;87(11):1448-54. doi: 10.1046/j.1365-2168.2000.01610.x.
8
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30. doi: 10.1046/j.1440-1746.2000.02097.x.
9
A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B.
J Viral Hepat. 2000 May;7(3):225-9. doi: 10.1046/j.1365-2893.2000.00216.x.
10
Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C.
J Viral Hepat. 2000 May;7(3):211-7. doi: 10.1046/j.1365-2893.2000.00215.x.
Zotero 插件